These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32164673)

  • 21. Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial.
    Garcia CJ; Haynes K; Pokorney SD; Lin ND; McMahill-Walraven C; Nair V; Parlett L; Martin D; Al-Khalidi HR; McCall D; Granger CB; Platt R; Cocoros NM
    Clin Trials; 2020 Aug; 17(4):360-367. PubMed ID: 32589056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
    King TE; Albera C; Bradford WZ; Costabel U; du Bois RM; Leff JA; Nathan SD; Sahn SA; Valeyre D; Noble PW
    Am J Respir Crit Care Med; 2014 Apr; 189(7):825-31. PubMed ID: 24476390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial.
    Loizeau AJ; D'Agata EMC; Shaffer ML; Hanson LC; Anderson RA; Tsai T; Habtemariam DA; Bergman EH; Carroll RP; Cohen SM; Scott EME; Stevens E; Whyman JD; Bennert EH; Mitchell SL
    Trials; 2019 Oct; 20(1):594. PubMed ID: 31615540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of droplet digital PCR rapid detection method and precise diagnosis and treatment for suspected sepsis (PROGRESS): a study protocol for a multi-center pragmatic randomized controlled trial.
    Zhao Y; Lin K; Zhang H; Yuan G; Zhang Y; Pan J; Hong L; Huang Y; Ye Y; Huang L; Chen X; Liu J; Li X; He X; Yue Q; Zhang H; Zhou A; Zhuang Y; Chen J; Wu C; Zhou W; Cai F; Zhang S; Li L; Li S; Bian T; Li J; Yin J; Ruan Z; Xu S; Zhang Y; Chen J; Zhang Y; Han J; Su T; Tu F; Jiang L; Lei C; Du Q; Ai J; Zhang W
    BMC Infect Dis; 2022 Jul; 22(1):630. PubMed ID: 35854212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
    Kahlmann V; Janssen Bonás M; Moor CC; van Moorsel CHM; Kool M; Kraaijvanger R; Grutters JC; Overgaauw M; Veltkamp M; Wijsenbeek MS;
    BMC Pulm Med; 2020 Oct; 20(1):271. PubMed ID: 33076885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.
    Nambiar A; Kellogg D; Justice J; Goros M; Gelfond J; Pascual R; Hashmi S; Masternak M; Prata L; LeBrasseur N; Limper A; Kritchevsky S; Musi N; Tchkonia T; Kirkland J
    EBioMedicine; 2023 Apr; 90():104481. PubMed ID: 36857968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.
    Crestani B; Huggins JT; Kaye M; Costabel U; Glaspole I; Ogura T; Song JW; Stansen W; Quaresma M; Stowasser S; Kreuter M
    Lancet Respir Med; 2019 Jan; 7(1):60-68. PubMed ID: 30224318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
    Borow KM; Yaroshinsky A; Greenberg B; Perin EC
    Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.
    Moodley Y; Corte T; Richeldi L; King TE
    Respirology; 2015 Apr; 20(3):389-94. PubMed ID: 25727967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia.
    Kowark A; Adam C; Ahrens J; Bajbouj M; Bollheimer C; Borowski M; Dodel R; Dolch M; Hachenberg T; Henzler D; Hildebrand F; Hilgers RD; Hoeft A; Isfort S; Kienbaum P; Knobe M; Knuefermann P; Kranke P; Laufenberg-Feldmann R; Nau C; Neuman MD; Olotu C; Rex C; Rossaint R; Sanders RD; Schmidt R; Schneider F; Siebert H; Skorning M; Spies C; Vicent O; Wappler F; Wirtz DC; Wittmann M; Zacharowski K; Zarbock A; Coburn M;
    BMJ Open; 2018 Oct; 8(10):e023609. PubMed ID: 30341135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
    Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis.
    Blackwell TS; Hewlett JC; Mason WR; Martin S; Del Greco J; Ding G; Wu P; Lancaster LH; Loyd JE; Dudenhofer RB; Salisbury ML; Kropski JA
    Ann Am Thorac Soc; 2021 Aug; 18(8):1291-1297. PubMed ID: 33740394
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis.
    Palmer SM; Snyder L; Todd JL; Soule B; Christian R; Anstrom K; Luo Y; Gagnon R; Rosen G
    Chest; 2018 Nov; 154(5):1061-1069. PubMed ID: 30201408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRagmatic trial Of Video Education in Nursing homes: The design and rationale for a pragmatic cluster randomized trial in the nursing home setting.
    Mor V; Volandes AE; Gutman R; Gatsonis C; Mitchell SL
    Clin Trials; 2017 Apr; 14(2):140-151. PubMed ID: 28068789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
    Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
    Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial.
    Laurens MB; Mungwira RG; Nyirenda OM; Divala TH; Kanjala M; Muwalo F; Mkandawire FA; Tsirizani L; Nyangulu W; Mwinjiwa E; Taylor TE; Mallewa J; Blackwelder WC; Plowe CV; Laufer MK; van Oosterhout JJ
    Trials; 2016 Jul; 17(1):322. PubMed ID: 27431995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access.
    Powell GA; Bonnett LJ; Tudur-Smith C; Hughes DA; Williamson PR; Marson AG
    Trials; 2017 Aug; 18(1):389. PubMed ID: 28835254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.
    Daniels CE; Lasky JA; Limper AH; Mieras K; Gabor E; Schroeder DR;
    Am J Respir Crit Care Med; 2010 Mar; 181(6):604-10. PubMed ID: 20007927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy.
    Spagnolo P; Maher TM; Richeldi L
    Pharmacol Ther; 2015 Aug; 152():18-27. PubMed ID: 25946646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
    Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.